PIP3 but not PIP2 increases GLUT4 surface expression and glucose metabolism mediated by AKT/PKCζ/λ phosphorylation in 3T3L1 adipocytes

Molecular and Cellular Biochemistry

Volumn 381, Issue 1-2, 2013, Pages 291-299

  Manna, Prasenjit ^a   Jain, Sushil K ^a  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

AKT; Diabetes; Glucose metabolism; GLUT4; PIP2; PIP3; PKC

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCEROPHOSPHOLIPID; INSULIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BIPHOSPHATE; PROTEIN KINASE B; PROTEIN KINASE C LAMBDA; PROTEIN KINASE C ZETA; RESISTIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; INSULIN SENSITIVITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; CELL MEMBRANE; CHEMOKINE CCL2; ENZYME ACTIVATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; ISOENZYMES; MICE; MODELS, BIOLOGICAL; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHORYLATION; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-AKT; RESISTIN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84882603424     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1714-7     Document Type: Article

References (34)

1. Pendaries C, Tronchère H, Plantavid M, Payrastre B (2003) Phosphoinositide signaling disorders in human diseases. FEBS Lett 546:25-31
2. Czech MP (2000) PIP2 and PIP3: complex roles at the cell surface. Cell 100:603-606
3. Hinchliffe KA (2001) Cellular signalling: stressing the importance of PIP3. Curr Biol 11:R371-R3373
4. Park WS, Heo WD, Whalen JH, O'Rourke NA, Bryan HM, Meyer T, Teruel MN (2008) Comprehensive identification of PIP3-regulated PH domains from C. elegans to H. sapiens by model prediction and live imaging. Mol Cell 30:381-392
5. Várnai P, Bondeva T, Tamás P, Tóth B, Buday L, Hunyady L, Balla T (2005) Selective cellular effects of overexpressed pleckstrin-homology domains that recognize PtdIns(3, 4, 5)P3 suggest their interaction with protein binding partners. J Cell Sci 118:4879-4888
6. Toker A (1998) The synthesis and cellular roles of phosphati-dylinositol- 4, 5-bisphosphate. Curr Opin Cell Biol 10:254-261
7. Taniguchi CM, Tran TT, Kondo T et al (2006) Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN. Proc Natl Acad Sci USA 103: 12093-12097
8. Butler M, McKay RA, Popoff IJ et al (2002) Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes 51:1028-1034
9. Ono H, Katagiri H, Funaki M et al (2001) Regulation of phos-phoinositide metabolism, AKT phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes. Mol Endocrinol 15: 1411-1422
10. Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806
11. Manna P, Jain SK (2011) Hydrogen sulfide and L-cysteine increase phosphatidylinositol-3, 4, 5-trisphosphate (PIP3) and glucose utilization by inhibiting phosphatase and tensin homolog (PTEN) protein and activating phosphoinositide 3-kinase (PI3K)/serine/threonine protein kinase (AKT)/protein kinase Cf/k (PKCf/k) in 3T3L1 adipocytes. J Biol Chem 286:39848-39859
12. Candiloros H, Muller S, Zeghari N, Donner M, Drouin P, Ziegler O (1995) Decreased erythrocyte membrane fluidity in poorly controlled IDDM. Influence of ketone bodies. Diabetes Care 18: 549-551
13. Jung DW, Ha HH, Zheng X, Chang YT, Williams DR (2011) Novel use of fluorescent glucose analogues to identify a new class of triazine-based insulin mimetics possessing useful secondary effects. Mol Biosyst 7:346-358
14. Koshy S, Alizadeh P, Timchenko LT, Beeton C (2010) Quantitative measurement of GLUT4 translocation to the plasma membrane by flow cytometry. J Vis Exp 45:e2429
15. Rains JL, Jain SK (2011) Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 50:567-575
16. Sasaki T, Sasaki J, Sakai T, Takasuga S, Suzuki A (2007) The physiology of phosphoinositides. Biol Pharm Bull 30:1599-1604
17. Bandyopadhyay G, Kanoh Y, Sajan MP, Standaert ML, Farese RV (2000) Effects of adenoviral gene transfer of wild-type, constitutively active, and kinase-defective protein kinase C-lambda on insulin-stimulated glucose transport in L6 myotu-bes. Endocrinology 141:4120-4127
18. Bandyopadhyay G, Standaert ML, Galloway L, Moscat J, Farese RV (1997) Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes. Endocrinology 138:4721-4731
19. Bandyopadhyay G, Standaert ML, Zhao L et al (1997) Activation of protein kinase C (alpha, beta, and zeta) by insulin in 3T3/L1 cells. Transfection studies suggest a role for PKC-zeta in glucose transport. J Biol Chem 272:2551-2558
20. Kotani K, Ogawa W, Matsumoto M et al (1998) Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol Cell Biol 18:6971-6982
21. Farese RV (2002) Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states. Am J Physiol Endocrinol Metab 283:E1-E11
22. Olson AL, Pessin JE (1996) Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annu Rev Nutr 16:235-256
23. Jiang T, Sweeney G, Rudolf MT, Klip A, Traynor-Kaplan A, Tsien RY (1998) Membrane-permeant esters of phosphatidylin-ositol-3, 4, 5-trisphosphate. J Biol Chem 273:11017-11024
24. Funaki M, DiFransico L, Janmey PA (2006) PI-4, 5-P2 stimulates glucose transport activity of GLUT4 in the plasma membrane of 3T3-L1 adipocytes. Biochim Biophys Acta 1763:889-899
25. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S et al (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295
26. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM et al (2001) The hormone resistin links obesity to diabetes. Nature 409:307-312
27. Egashira K (2003) Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemo-attractant protein-1. Hypertension 41:834-841
28. Beeson M, Sajan MP, Dizon M, Grebenev D, Gomez-Daspet J, Miura A et al (2003) Activation of protein kinase C-zeta by insulin and phosphatidylinositol- 3, 4, 5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise. Diabetes 52:1926-1934
29. Kim YB, Kotani K, Ciaraldi TP, Henry RR, Kahn BB (2003) Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction. Diabetes 52:1935-1942
30. Xiao H, Liu M (2012) Atypical protein kinase C in cell motility. Cell Mol Life Sci (in press)
31. Hirai T, Chida K (2003) Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions. J Biochem 133:1-7
32. Beeson M, Sajan MP, Daspet JG, Luna V, Dizon M, Grebenev D et al (2004) Defective activation of protein kinase C-z in muscle by insulin and phosphatidylinositol-3, 4, 5, -(PO(4))(3) in obesity and polycystic ovary syndrome. Metab Syndr Relat Disord 2:49-56
33. Vollenweider P, Menard B, Nicod P (2002) Insulin resistance, defective insulin receptor substrate 2-associated phosphatidylin-ositol- 3-kinase activation, and impaired atypical protein kinase C (f/k) activation in myotubes from obese patients with impaired glucose tolerance. Diabetes 15:1052-1059
34. Luna V, Casauban L, Sajan MP, Gomez-Daspet J, Powe JL, Miura A et al (2006) Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3, 4, 5-(PO4)3 in muscle of diabetic subjects. Diabetologia 49:375-382